Medicare Enrolled
Dr. Kent Small, MD
Retina Specialist (Ophthalmology) Physician · Glendale, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Small from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Small?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Small
Dr. Kent Small is a retina specialist physician in Glendale, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Small performed 73,379 Medicare services across 5,480 unique beneficiaries.
Between the years covered by Open Payments, Dr. Small received a total of $27,524 from 43 pharmaceutical and/or device companies across 659 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in retina specialist (ophthalmology) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Small is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 3% volume in CA
$27,524 industry payments
Medicare Practice Summary
Medicare Utilization ↗73,379
Medicare services
Top 3% in CA for retina specialist (ophthalmology) physician
5,480
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,669 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) An injection of faricimab-svoa, a medication administered in 0.1 mg doses. |
56,580 | $29 | $40 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
3,758 | $108 | $200 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
2,407 | $98 | $370 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
2,294 | $35 | $100 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
1,833 | $28 | $127 |
| Ranibizumab-nuna biosimilar injection, 0.1 mg An injection of the biosimilar medication ranibizumab-nuna (Byooviz) at a dose of 0.1 mg. |
1,495 | $171 | $300 |
| Injection, ranibizumab, 0.1 mg | 1,114 | $179 | $450 |
| Retinal angiography with dye injection This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body. |
708 | $120 | $223 |
| Compounded drug, not otherwise classified A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products. |
662 | $73 | $200 |
| Pegcetacoplan intravitreal injection, 1 mg An injection of pegcetacoplan administered into the vitreous humor of the eye. The dose specified is 1 milligram. |
495 | $120 | $200 |
| Extended eye exam with retinal drawing A detailed examination of the back of the eye that includes creating a drawing of the retina. |
360 | $21 | $50 |
| Aflibercept eye injection (Eylea) | 296 | $649 | $1,200 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
251 | $124 | $224 |
| Fluorescein angiography of retina A special camera captures images of the blood vessels in the retina and the area between the white part of the eye and the retina after a dye is injected. |
230 | $234 | $400 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
222 | $48 | $124 |
| Dexamethasone intravitreal implant injection An injection of a dexamethasone implant placed inside the eye. This procedure delivers medication directly into the vitreous cavity of the eye. |
161 | $157 | $230 |
| Retinal and optic nerve function test A diagnostic test that measures the function of the retina and optic nerve at multiple specific locations. |
128 | $76 | $245 |
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
108 | $28 | $75 |
| Ultrasound of eye tissue and structures A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures. |
55 | $39 | $235 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
54 | $73 | $108 |
| Retinal and optic nerve function test A diagnostic test that measures how well the retina and optic nerve are functioning. |
53 | $110 | $250 |
| Visual evoked potential test A test that measures how quickly electrical signals travel from the eye to the brain in response to visual stimuli. |
41 | $61 | $240 |
| Retinal laser destruction of growth A laser procedure used to destroy abnormal growths in the retina. |
39 | $427 | $1,200 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
18 | $46 | $127 |
| Retinal photocoagulation to prevent detachment This procedure uses laser light to create small burns on the retina. It is performed to help prevent the retina from detaching from the back of the eye. |
17 | $200 | $2,500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$27,524
Total received (2018-2024)
Avg $3,932/year across 7 years
Top 9% in CA for retina specialist (ophthalmology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
659
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,200 (73.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,044 (25.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$280 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$9,762
2023
$3,181
2022
$2,621
2021
$2,578
2020
$1,794
2019
$2,402
2018
$5,187
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$3,932
EyePoint Pharmaceuticals US, Inc.
$1,819
Bausch & Lomb Americas Inc.
$824
Astellas Pharma US Inc
$616
Apellis Pharmaceuticals, Inc.
$448
Oyster Point Pharma, Inc.
$436
Biogen, Inc.
$387
SUN PHARMACEUTICAL INDUSTRIES INC.
$357
Regeneron Healthcare Solutions, Inc.
$265
Genentech USA, Inc.
$179
Alcon Vision LLC
$157
Tarsus Pharmaceuticals, Inc.
$151
ABBVIE INC.
$103
Alimera Sciences, Inc.
$58
ANI Pharmaceuticals, Inc.
$31
Top 3 companies account for 67.4% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$3,932
EyePoint Pharmaceuticals US, Inc.
$2,532
Mallinckrodt LLC
$1,962
Novartis Pharmaceuticals Corporation
$1,914
Allergan, Inc.
$1,406
Bausch & Lomb Americas Inc.
$1,252
Regeneron Healthcare Solutions, Inc.
$1,243
Alimera Sciences, Inc.
$1,190
Genentech USA, Inc.
$1,175
Bausch & Lomb, a division of Bausch Health US, LLC
$1,064
Sun Pharmaceutical Industries Inc.
$1,007
Oyster Point Pharma, Inc.
$932
Astellas Pharma US Inc
$860
Dutch Ophthalmic Research Center (International) B.V.
$850
Apellis Pharmaceuticals, Inc.
$692
Shire North American Group Inc
$652
Biogen, Inc.
$625
SUN PHARMACEUTICAL INDUSTRIES INC.
$577
Aerie Pharmaceuticals, Inc.
$460
Carl Zeiss Meditec, Inc.
$358
Mallinckrodt Enterprises LLC
$301
Notal Vision, Inc.
$280
Eyevance Pharmaceuticals LLC
$243
VisionCare Inc.
$241
ABBVIE INC.
$225
Coherus Biosciences Inc.
$223
Alcon Vision LLC
$216
Allergan Inc.
$168
Carl Zeiss Meditec USA, Inc.
$166
Tarsus Pharmaceuticals, Inc.
$151
Horizon Therapeutics plc
$122
Kala Pharmaceuticals, Inc.
$81
EYEVANCE PHARMACEUTICALS LLC
$72
OPTOS, INC.
$56
AbbVie Inc.
$48
Alcon Laboratories Inc
$45
Dutch Ophthalmic, USA
$41
Optos, Inc.
$36
Akorn Operating Company LLC
$36
ANI Pharmaceuticals, Inc.
$31
ThromboGenics, Inc.
$25
Spark Therapeutics, Inc.
$18
Vyera Pharmaceuticals, LLC
$16
Top 3 companies account for 30.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALREX · BEOVU · BESIVANCE · BROMSITE · BYOOVIZ · BromSite (bromfenac ophthalmic solution) 0.075% · CEQUA · CLARUS · COMBIGAN · Centurion · Cequa · Cimerli · Constellation · DEXYCU · DURYSTA · Daraprim Tablet 25mg · EQ Workplace · EVA · EVA Ophthalmic Surgical System · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · EYP-1901 · Flarex · ILUVIEN · INVELTYS · Iluvien · Implantable Miniature Telescope · Izervay · Jetrea · LOTEMAX · LOTEMAX SM · LUMAKRAS · Lucentis · MIEBO · OPMI Lumera · OZURDEX · P200DTx · PANORAMIC OPHTHALMOSCOPE · PROLENSA · PURIFIED CORTROPHIN GEL · RESTASIS · RESTASIS MULTIDOSE · Rhopressa · Rocklatan · Simbrinza · Syfovre · TEPEZZA · TRAVATAN Z · TYRVAYA · TobraDex ST · Tobradex ST · VISUDYNE · VYZULTA · Vabysmo · XDEMVY · XELPROS · XIIDRA · XIPERE · YUTIQ · Zerviate · Zioptan · combined machine · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (73%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for retina specialist (ophthalmology) physician in CA.
Geographic Context
Retina specialist physicians within 10 mi
30
Per 100K population
0.3
County median income
$87,760
Nearest hospital
GLENDALE MEM HOSPITAL & HLTH CENTER
1.2 mi
1.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Small is a mixed practice specialist, with above-average Medicare volume (top 3% in CA), with low-engagement industry engagement in the top 9% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Small experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Small performed 56,580 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Small receive payments from pharmaceutical companies?
Yes. Dr. Small received a total of $27,524 from 43 companies across 659 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Small's costs compare to other retina specialist physicians in Glendale?
Dr. Small's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Small) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Retina Specialist Physicians in Glendale
Browse retina specialist physicians in Glendale ranked by procedure volume and transparency data.
Highest volume
Top Retina Specialist Physicians in CA
Retina specialist physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Retina Specialist Physicians in CA
Which CA retina specialist physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
EyePoint Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from EyePoint Pharmaceuticals US, Inc.
By company
Mallinckrodt LLC Payments to Doctors
See all physicians who received payments from Mallinckrodt LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology